1. International Liver Cancer Association st Annual Conference October 5 – October 6, Barcelona, Spain

2. Mission The International Liver Cancer Association (ILCA) aims at advancing research in the pathogenesis, prevention, and treatment of liver cancer. It promotes novel pathogenic, diagnostic and therapeutic interventions for liver cancer by taking a transversal approach to research and bringing together scientists, physicians and allied professionals from all interrelated fields.

3. Conference Report

4. Facts - State of the art sessions and symposia proposed - An outstanding panel of renowned speakers persons attended this event from 37 different countries - Multi-disciplinary and professional scope attracted clinical, translational and basic researchers, physicians and allied professionals from around the globe.

5. Abstracts 305 abstracts received 298 abstracts selected 30 Oral communications 17 Top-scored posters on display for two days 241 posters on display for one day

6. Registration Statistics Total registrations: ILCA members: Non member: Early Registrations: Late Registrations: On site Registrations:

7. Registration Demographics Number of countries represented: 37 Continents Top 5 Countries Europe: % Spain (81) North America: 14% United States (63) Asia & Australia: 14% France (57) Africa: % Italy (47) South America: 2% Germany (44)

8. Sponsors

9. Main Sponsors Platinum Sponsor Silver Sponsors Symposium Sponsor

10. Other Sponsors Cisbio International. (advertisment) Covidien frm
Other Sponsors Cisbio International (advertisment) Covidien frm. Tyco Healthcare (stand) Eisai (grant) National Institutes of Health (grant) Philips (stand) Raptor Pharma (grant) Sirtex (internet café & stand)